Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.
Larrousse M, Laguno M, Segarra M, De Lazzari E, Martinez E, Blanco JL, León A, Deulofeu R, Miquel R, Milinkovic A, Lonca M, Miró JM, Biglia A, Murillas J, Gatell JM, Mallolas J. Larrousse M, et al. J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):304-11. doi: 10.1097/qai.0b013e3181520502. J Acquir Immune Defic Syndr. 2007. PMID: 18172937
Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients.
Laguno M, Larrousse M, Blanco JL, Leon A, Milinkovic A, Martínez-Rebozler M, Loncá M, Martinez E, Sanchez-Tapias JM, de Lazzari E, Gatell JM, Costa J, Mallolas J. Laguno M, et al. Among authors: larrousse m. AIDS Res Hum Retroviruses. 2008 Apr;24(4):547-53. doi: 10.1089/aid.2007.9994. AIDS Res Hum Retroviruses. 2008. PMID: 18393687
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.
Laguno M, Murillas J, Blanco JL, Martínez E, Miquel R, Sánchez-Tapias JM, Bargallo X, García-Criado A, de Lazzari E, Larrousse M, León A, Loncá M, Milinkovic A, Gatell JM, Mallolas J. Laguno M, et al. Among authors: larrousse m. AIDS. 2004 Sep 3;18(13):F27-36. doi: 10.1097/00002030-200409030-00003. AIDS. 2004. PMID: 15316335 Clinical Trial.
[Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection].
Laguno M, Sánchez-Tapias JM, Murillas J, Forns X, Blanco JL, Martínez E, Larrousse M, León A, Loncá M, Milinkovic A, Miró JM, García F, Gatell JM, Mallolas J. Laguno M, et al. Among authors: larrousse m. Enferm Infecc Microbiol Clin. 2005 Jan;23(1):32-40. doi: 10.1157/13070408. Enferm Infecc Microbiol Clin. 2005. PMID: 15701331 Review. Spanish.
Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin.
Laguno M, Larrousse M, Murillas J, Blanco JL, León A, Milinkovic A, Loncá M, Martinez E, Sánchez-Tapias JM, de Lazzari E, Gatell JM, Costa J, Mallolas J. Laguno M, et al. Among authors: larrousse m. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):174-8. doi: 10.1097/QAI.0b013e31802b812d. J Acquir Immune Defic Syndr. 2007. PMID: 17106276 Clinical Trial.
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption.
León A, Martinez E, Milinkovic A, Mora B, Mallolas J, Blanco JL, Larrousse M, Laguno M, Gallart T, Plana M, Gatell JM, Garcia F. León A, et al. Among authors: larrousse m. J Antimicrob Chemother. 2009 Jan;63(1):184-8. doi: 10.1093/jac/dkn461. Epub 2008 Nov 11. J Antimicrob Chemother. 2009. PMID: 19001447
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
Laguno M, Cifuentes C, Murillas J, Veloso S, Larrousse M, Payeras A, Bonet L, Vidal F, Milinkovic A, Bassa A, Villalonga C, Pérez I, Tural C, Martínez-Rebollar M, Calvo M, Blanco JL, Martínez E, Sánchez-Tapias JM, Gatell JM, Mallolas J. Laguno M, et al. Among authors: larrousse m. Hepatology. 2009 Jan;49(1):22-31. doi: 10.1002/hep.22598. Hepatology. 2009. PMID: 19085908 Clinical Trial.
73 results